Neurizon Therapeutics Ltd

NEW
ASX:NUZ (Australia)  
A$ 0.062 +0.0025 (+4.2%) Jul 31
At Loss
P/B:
4.14
Market Cap:
A$ 48.06M ($ 33.60M)
Enterprise V:
A$ 41.75M ($ 29.19M)
Volume:
577.24K
Avg Vol (2M):
1.00M
Trade In:
Volume:
577.24K
At Loss
Avg Vol (2M):
1.00M

Neurizon Therapeutics Ltd (ASX:NUZ) Dividend

Neurizon Therapeutics Ltd (ASX:NUZ) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -15.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: ASX:NUZ Dividend

Does Neurizon Therapeutics Ltd (ASX:NUZ) pay a dividend?

Neurizon Therapeutics Ltd (ASX:NUZ) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Neurizon Therapeutics Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Neurizon Therapeutics Ltd has returned capital to shareholders via buybacks at a rate of -15.8% over the past 3 years.

What are dividend-paying alternatives to Neurizon Therapeutics Ltd?

For dividend-paying alternatives in Neurizon Therapeutics Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.